Unna boot central gauze technique for chronic venous leg ulcers.
BACKGROUND
Venous leg ulcers generally take manyweeks to heal. Novel therapies that shorten healingtime and require less complex care are needed.


OBJECTIVE
The purpose of this report is to presenta pilot study for a new method that can result ina faster healing time for venous leg ulcers usinginexpensive materials.


METHODS
A central-gauzeprotocol was developed as described here. A three-ply gauze sponge was placed in the center of theulcer, allowing a peripheral 3-5 mm rim of ulcer toremain exposed. Saline solution was applied to thegauze sponge. A 3-layer Unna boot was applied overthe ulcer with short-stretch compression. This noveltechnique exposed only a peripheral rim of the ulcerto the zinc oxide paste, allowing the central portionof the ulcer to drain through the saline-soaked gauze.The ulcer was photographed at each clinic visit andthe wound area was estimated by finding the bestfitellipse for the ulcer area and computing the areaof the ellipse by a standard formula.


RESULTS
Threepatients with small venous leg ulcers treated with thezinc rim technique showed an average healing rate of46.1% per week (range 27.8% - 50.7%). All ulcers werenearly healed by three weeks. After the ulcer size wasreduced sufficiently, patients were discharged withinstructions to apply pieces of Unna dressing to theulcer, under a conventional self-adhesive bandage,maintaining compression, without any saline-gauzein the center.


CONCLUSIONS
The three patients in thispilot study showed rapid healing for venous leg ulcerswith the central gauze modification of Unna boottherapy.
Anne L
AL
Gao
Justin G
JG
Cole
S&A Technologies, LLC,Rolla, Missouri. wvs@mst.edu.
William V
WV
Stoecker
D000368:Aged; D000369:Aged, 80 and over; D001458:Bandages; D058128:Compression Bandages; D004338:Drug Combinations; D005260:Female; D005780:Gelatin / Q000627:therapeutic use*; D005990:Glycerol / Q000627:therapeutic use*; D006801:Humans; D010865:Pilot Projects; D012965:Sodium Chloride / Q000627:therapeutic use; D016896:Treatment Outcome; D014647:Varicose Ulcer / Q000628:therapy*; D017967:Zinc Compounds / Q000627:therapeutic use*
D004338:Drug Combinations; D017967:Zinc Compounds; C009622:gelatin, glycerin, zinc oxide drug combination; D012965:Sodium Chloride; D005780:Gelatin; D005990:Glycerol